At 7.56% CAGR, Global Cervical Dysplasia Market Size to Hit USD 974.11 Million by 2028 | Cervical Dysplasia Industry Trends, Share, Price, Demand, Analysis & Forecast Report by Facts & Factors

The global cervical dysplasia market size was valued at USD 584.86 million in 2021 and is expected to surpass USD 974.11 million by 2028, registering a CAGR of 7.56% during the forecast period (2022- 2028), as highlighted in a report published by Facts & Factors. The key market players are listed in the report with their sales, revenues and strategies are Qiagen N.V.; Quest Diagnostics; Abbott Laboratories; Hologic Inc.; Karl Kaps GmbH & Co. KG; DYSIS Medical Ltd.; CooperSurgical Inc.; Micromedic Technologies Ltd.; OncoHealth Corporation Inc.; BD; Roche., and others.


NEW YORK, United States, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Cervical Dysplasia Market Size, Share, Growth Analysis Report By Diagnosis Type (Diagnostic Tests, Diagnostic Devices), By End Use (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028” in its research database.

What will be the value of the global cervical dysplasia market during 2022-2028?

“According to the latest research study, the demand of global cervical dysplasia market size & share was valued at approximately USD 584.86 million in 2021. The market is expected to grow above a compound annual growth rate (CAGR) of 7.56% and is anticipated to reach over USD 974.11 million by 2028.”

The report analyzes the cervical dysplasia market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the global cervical dysplasia market.

Cervical Dysplasia Market Overview:

The rise in publicly supported cancer screening programs is one of the key factors driving the global cervical dysplasia market. For instance, Public Health England launched the first government campaign to increase awareness of cervical dysplasia screening using smear tests in March 2019.

The percentage of women aged 25 and older who receive smear tests is currently at its lowest point in two decades, according to the same source, as a result of the stigma and dread associated with the Pap test.

Get a Free Sample PDF of this Research Report for more Insights - https://www.fnfresearch.com/sample/cervical-dysplasia-market

(A free sample of this report is available upon request; please contact us for more information.)

Our Free Sample Report Consists of the Following:

  • Introduction, Overview, and in-depth industry analysis are all included in the updated report.
  • The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
  • About 207+ Pages Research Report (Including Recent Research)
  • Provide detailed chapter-by-chapter guidance on Request
  • Updated Regional Analysis with Graphical Representation of Size, Share, and Trends
  • Includes Tables and figures have been updated
  • The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, Revenue Analysis, SWOT Analysis, Historic and Forecast Growth, Porter's 5 Forces Analysis
  • Facts and Factors research methodology

Key Insights from Primary Research

  • As per the analysis, the Cervical Dysplasia market is likely to grow above a CAGR of around 7.56% between 2022 and 2028.
  • The Cervical Dysplasia market size was worth around US$ 584.86 million in 2021 and is estimated to hit approximately US$ 974.11 million by 2028. Due to a variety of driving factors, the market is predicted to rise at a significant rate.
  • Based on type segmentation, diagnostic test was predicted to show maximum market share in the year 2021
  • Based on end user segmentation, hospital was predicted to show maximum market share in the year 2021.
  • On the basis of region, North America was the leading revenue generator in 2021.

Which key factors will influence global cervical dysplasia market growth over 2022-2028?

Industry Growth Drivers:

Around 71.4% of women were screened in March 2018, according to data from NHS Digital. PHE recently started a campaign to spread awareness across several platforms in England by collaborating with major media outlets and a number of social media platforms. Thus, a rise in the number of initiatives undertaken by the government to enhance the screening of cervical dysplasia is expected to boost market growth in the near future.

Growing efforts to raise awareness of the condition by the governments of various nations are anticipated to help the market in the future. Hospitals have also adopted a number of initiatives, which is projected to increase the market size throughout the forecast period. Other significant drivers shaping the global cervical dysplasia market include the availability of technologically improved diagnostic tools and growing healthcare infrastructure. The year 2017 saw the launch of the "Smear your Mea" New Zealand Health campaign. The program attempts to encourage women to obtain smear tests and to stop the spread of cancer.

Another significant factor driving the market's development is the expansion of hospital alliances. B.C. Women's Hospital and Health Centre, an organization under the Provincial Health Services Authority, established cooperation with Surrey's many family doctors and other communities in May 2019 to reach out to women who find regular screening of the disease difficult. Such elements are probably going to help industry growth during the assessment period.

Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/cervical-dysplasia-market

Cervical Dysplasia Market: COVID-19 Impact Analysis

The global cervical dysplasia market as well as the global healthcare systems have both been significantly impacted by the COVID-19 pandemic. According to a report in Cancer Connect 2020, researchers from the Dana Farber Cancer Institute discovered that during the COVID-19 pandemic, diagnoses of the six most common cancer types—breast, colorectal, lung, pancreatic, gastric, and esophageal cancers—declined by 46%.

The Centers for Disease Control and Prevention (CDC) and numerous other medical professional organizations also recommended delaying elective surgeries, cancer screenings, and other health prevention services unless the risks outweighed the benefits and preparing the hospital infrastructure for the care of COVID-19 patients.

Which are the major players leveraging the global cervical dysplasia market growth?

Competitive Players

The report contains qualitative and quantitative research on the global cervical dysplasia market, as well as detailed insights and development strategies employed by the leading competitors. The report also provides an in-depth analysis of the market's main competitors, as well as information on their competitiveness.

The research also identifies and analyses important business strategies used by these main market players, such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts.

Some of the main players in the global Cervical Dysplasia market include;

  • Qiagen N.V.
  • Quest Diagnostics
  • Abbott Laboratories
  • Hologic Inc.
  • Karl Kaps GmbH & Co. KG
  • DYSIS Medical Ltd.
  • CooperSurgical Inc.
  • Micromedic Technologies Ltd.
  • OncoHealth Corporation Inc.
  • BD
  • Roche

Browse the full “Cervical Dysplasia Market Size, Share, Growth Analysis Report By Diagnosis Type (Diagnostic Tests, Diagnostic Devices), By End Use (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028” Report at https://www.fnfresearch.com/cervical-dysplasia-market

Cervical Dysplasia Market: Segmentation Analysis

The global cervical dysplasia market is segmented based on type, end-user, and region.

Based on type, the market is segmented into diagnostic tests and diagnostics devices. Cervical dysplasia diagnostic tests controlled the market. This is because of its effectiveness, adaptability, reimbursement procedures, and economic efficiency. These tests have a better penetration in low- and middle-income nations as a result of their cost-effectiveness.

Based on end-user, the market is segmented into hospitals, Diagnostic Centers, and Ambulatory Surgical Centers. Cervical dysplasia was mostly sold by hospitals. This is because there are numerous payments plans and technologically sophisticated diagnostic tools and tests available. Additionally, advancing medical infrastructure has made it possible for hospitals to outfit various technologically sophisticated diagnostic devices, boosting both diagnostic effectiveness and overall patient happiness.

Which region will contribute notably towards the global cervical dysplasia market value?

Regional Analysis:

In 2021, North America dominated the global cervical dysplasia market and generated the biggest revenue share. Throughout the projection period, it is anticipated that the region would keep its position.

The region's cervical dysplasia market is expected to be driven by factors including technological advancements, an increase in the prevalence of various associated diseases, rising awareness and screening programs, and supportive initiatives by public and private organizations to increase the adoption of HPV testing.

Have Any Query? Ask Our Experts: https://www.fnfresearch.com/inquiry/cervical-dysplasia-market

Recent Industry Developments:

  • In June 2022, F. Hoffmann-La Roche Ltd, a Swiss multinational healthcare company, announced the official launch of a ‘human papillomavirus (HPV) self-sampling solution’ in the regions accepting the CE mark. This test kit mainly helps in screening for HPV, which can detect women who are at risk of developing cervical cancer.
  • In January 2022, SANSURE BIOTECH INC., an in-vitro diagnostic products supplier, announced that its ‘HPV DNA Diagnostic Kit (HPV 13+2)’ was approved by the China National Medical Products Administration (NMPA). The kit is developed with advanced magnetic beads technology and above 13 kinds of high-risk genotypes to assure that the kit is capable of cervical cancer screening.

Key questions answered in this report:

  • What is the market size and growth rate forecast for Cervical Dysplasia industry?
  • What are the main driving factors propelling the Cervical Dysplasia Market forward?
  • What are the leading companies in the Cervical Dysplasia Industry?
  • What segments does the Cervical Dysplasia Market cover?
  • How can I receive a free copy of the Cervical Dysplasia Market sample report and company profiles?

Report Scope:

Report Attribute Details
Market Size in 2021 USD 584.86 Million
Projected Market Size in 2028 USD 974.11 Million
CAGR Growth Rate 7.56% CAGR
Base Year 2021
Forecast Years 2022-2028
Key Market Players Qiagen N.V.; Quest Diagnostics; Abbott Laboratories; Hologic Inc.; Karl Kaps GmbH & Co. KG; DYSIS Medical Ltd.; CooperSurgical Inc.; Micromedic Technologies Ltd.; OncoHealth Corporation Inc.; BD; Roche., and others.
Key Segment By Diagnosis Type, End Use, and Region
Major Regions Covered North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa
Purchase Options Request customized purchase options to meet your research needs.

Request for Customization on this Report as per your requirements - https://www.fnfresearch.com/customization/cervical-dysplasia-market

(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)

Still, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?

Email Directly Here with Detail Information: sales@fnfresearch.com

The global Cervical Dysplasia market is segmented as follows:

By Diagnosis Type

  • Diagnostic Tests
  • Diagnostic Devices

By End Use

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
    • Rest of Southeast Asia
  • The Middle East & Africa
    • GCC
    • South Africa
    • Rest of the Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

Request Your Free Sample Report of the Global Cervical Dysplasia Market @ https://www.fnfresearch.com/sample/cervical-dysplasia-market

Key Offerings:

  • Market Size, Trends, & Forecast by Revenue | 2022−2028
  • Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
  • Market Segmentation – A detailed analysis by Diagnosis Type, End Use, and Region
  • Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Browse Other Related Research Reports from Facts & Factors

  • Asthma Drugs Market Size, Share, Growth Analysis Report By Mode Of Administration (Injections, Inhalers, Tablets & Capsules, Sprays & Powders, and Liquids), By Medication (Long-Term Control Medications, and Quick Relief Medications), By Application (Adults, Pediatric, and Adolescent), By Source (Generic, and Environmental), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030
  • Injectable Drug Delivery Devices Market Size, Share, Growth Analysis Report By End-User (Hospitals, Homecare, and Ambulatory Services), By Type (Injectors, Syringes, and Pumps), By Application (Oncology, Autoimmune Diseases, Respiratory Therapy, Pain Management, and Others), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030
  • Artificial Tendons and Ligaments Market Size, Share, Growth Analysis Report By Application (Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries, Spine Injuries, Hip Injuries, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Others), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028
  • Medical Device Packaging Market Size, Share, Growth Analysis Report By Material Type (Plastic, Paper & Paperboard, Aluminum, and Other Material Types), By Product Type (Pouches, Bags, Trays, Boxes, Clam Shells, and Other Product Types), By Application (Sterile Packaging and Non-sterile Packaging), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028
  • Medical Perfusion Technology Market By Technology (Hypothermic Machine Perfusion & Normothermic Machine Perfusion), By Organ Type (Heart, Lung, Kidney, Liver, & Others), By Component (Perfusion Pumps, Oxygenators, Heart-Lung Machines, Monitoring Systems, Cannular, & Others), And By Region - Global and Regional Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026
  • In Vitro Fertilization (IVF) Market By Type (Conventional IVF, IVF with ICSI, IVF with Donar Eggs, Others), By Cycle (Fresh Non-donor IVF Cycles, Frozen Non-donor IVF Cycles, Frozen Donor IVF Cycles, Fresh Donor IVF Cycle), By Product (Equipment, Sperm Analyzer Systems, Imaging Systems, Ovum Aspiration Pumps, Micromanipulator Systems, Incubators, Gas Analyzers, Laser Systems, Cryosystems, Sperm Separation Devices, IVF Cabinets, Anti-vibration Tables, Witness Systems, Other Equipment, Reagents & Media, Cryopreservation Media, Embryo Culture Media, Ovum Processing Media, Sperm Processing Media, Accessories), By End User (Fertility Clinics, Hospitals & Surgical Centers, Cryobanks, Research Institutes), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecast 2022–2028
  • Dietary Supplements Market By Type (Botanicals, Vitamins, Minerals, Amino Acids, Enzymes, Probiotics, Other Dietary Supplements), By Function (Additional Supplements, Medicinal Supplements, Sports Nutrition), By Target Consumer (Infant, Children, Adults, Pregnant Women, Elderly), By Mode of Application (Tablets, Capsules, Powders, Liquids, Soft Gels, Gel Caps), and By Region - Global Industry Insights, Growth, Size, Share, Comparative Analysis, Trends and Forecast 2022 – 2028
  • Tampon Market Size, Share, Growth Analysis Report By Source (Organic, Conventional), By Nature (Scented, Unscented), By Pack Size (Less Than 10, 10-30, 31-50, 50 & Above), By Price Range (Economy, Mid-range, Premium), By Sales Channel (Wholesalers/Distributors, Hypermarkets/ Supermarkets, Drug Stores/ Pharmacies, Multi-brand Stores, Specialty Stores, Online Retailers, Other Sales Channels), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028

About Facts & Factors:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:

Facts & Factors

USA: +1 347 690-0211 | UK: +44 2032 894158 | Japan: +81 50 5806 9039 | India: +91 73877 19999

Email: sales@fnfresearch.com | Web: https://www.fnfresearch.com

Follow Us on - LinkedIn | Twitter | Facebook

 Also Read Our Blogs: